INTRODUCTION: Our study primarily aimed at investigating the effect of isoproterenol infusion on tissue oxygen saturation in patients with septic shock. The secondary aim was to assess the relation between cardiac index, central venous oxygen saturation and tissue oxygen saturation. METHODS: This retrospective study was conducted from December 2010 to March 2012. We included 14 consecutive patients with septic shock treated with isoproterenol. All patients were monitored by cardiac index and tissue oxygen saturation. From medical charts, routine hemodynamic data were extracted one hour before and six hours after the onset of isoproterenol infusion. RESULTS: From baseline to H6, tissue oxygen saturation levels rise from 78 [72-82]% to 85 [78-88]% (p = 0.03). Isoproterenol infusion was associated with an increase of central venous oxygen saturation (from 67 [65-74]% to 84 [77-86]%, p = 0.02) and cardiac index (from 2.9 [2.7-3.1] L/min/m² to 3.9 [3.0-4.4] L/min/m², p = 0.006). Tissue oxygen saturation was correlated neither to cardiac index (p = 0.14, R(2) = 0.08) nor to central venous oxygen saturation (p = 0.19, R(2) = 0.10). CONCLUSIONS: Use of isoproterenol was associated with an increase of tissue oxygen saturation. This increase was not correlated to cardiac index, suggesting a decoupling between macrocirculation and microcirculation.
INTRODUCTION: Our study primarily aimed at investigating the effect of isoproterenol infusion on tissue oxygen saturation in patients with septic shock. The secondary aim was to assess the relation between cardiac index, central venous oxygen saturation and tissue oxygen saturation. METHODS: This retrospective study was conducted from December 2010 to March 2012. We included 14 consecutive patients with septic shock treated with isoproterenol. All patients were monitored by cardiac index and tissue oxygen saturation. From medical charts, routine hemodynamic data were extracted one hour before and six hours after the onset of isoproterenol infusion. RESULTS: From baseline to H6, tissue oxygen saturation levels rise from 78 [72-82]% to 85 [78-88]% (p = 0.03). Isoproterenol infusion was associated with an increase of central venous oxygen saturation (from 67 [65-74]% to 84 [77-86]%, p = 0.02) and cardiac index (from 2.9 [2.7-3.1] L/min/m² to 3.9 [3.0-4.4] L/min/m², p = 0.006). Tissue oxygen saturation was correlated neither to cardiac index (p = 0.14, R(2) = 0.08) nor to central venous oxygen saturation (p = 0.19, R(2) = 0.10). CONCLUSIONS: Use of isoproterenol was associated with an increase of tissue oxygen saturation. This increase was not correlated to cardiac index, suggesting a decoupling between macrocirculation and microcirculation.
Authors: Christopher G Ellis; Ryon M Bateman; Michael D Sharpe; William J Sibbald; Ravi Gill Journal: Am J Physiol Heart Circ Physiol Date: 2002-01 Impact factor: 4.733
Authors: Y Mahjoub; V Lejeune; L Muller; S Perbet; L Zieleskiewicz; F Bart; B Veber; C Paugam-Burtz; S Jaber; A Ayham; E Zogheib; S Lasocki; A Vieillard-Baron; H Quintard; O Joannes-Boyau; G Plantefève; P Montravers; S Duperret; M Lakhdari; N Ammenouche; E Lorne; M Slama; H Dupont Journal: Br J Anaesth Date: 2013-12-29 Impact factor: 9.166
Authors: Marc Leone; Ioanna Boyadjiev; Emile Boulos; Francois Antonini; Pierre Visintini; Jacques Albanèse; Claude Martin Journal: Shock Date: 2006-10 Impact factor: 3.454
Authors: Daniel De Backer; Jacques Creteur; Marc-Jacques Dubois; Yasser Sakr; Marc Koch; Colin Verdant; Jean-Louis Vincent Journal: Crit Care Med Date: 2006-02 Impact factor: 7.598
Authors: R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent Journal: Crit Care Med Date: 2008-01 Impact factor: 7.598
Authors: Andrea Morelli; Abele Donati; Christian Ertmer; Sebastian Rehberg; Matthias Lange; Alessandra Orecchioni; Valeria Cecchini; Giovanni Landoni; Paolo Pelaia; Paolo Pietropaoli; Hugo Van Aken; Jean-Louis Teboul; Can Ince; Martin Westphal Journal: Crit Care Date: 2010-12-23 Impact factor: 9.097
Authors: Hernando Gómez; Jaume Mesquida; Peter Simon; Hyung Kook Kim; Juan C Puyana; Can Ince; Michael R Pinsky Journal: Crit Care Date: 2009-11-30 Impact factor: 9.097
Authors: Rick Bezemer; Alexandre Lima; Dean Myers; Eva Klijn; Michal Heger; Peter T Goedhart; Jan Bakker; Can Ince Journal: Crit Care Date: 2009-11-30 Impact factor: 9.097
Authors: Christian Radke; Dagmar Horn; Christian Lanckohr; Björn Ellger; Michaela Meyer; Thomas Eissing; Georg Hempel Journal: Clin Pharmacokinet Date: 2017-07 Impact factor: 6.447